Analyst Profile

Followed by 151 followers
.
Rick Wise

Rick Wise

Stifel Nicolaus
Wall Street Analyst
#550 out of 8,160 Wall Street Analysts
#1,101 out of 24,427 experts

Success Rate

61%
240 out of 391 transactions made a profit

Average Return

+7.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Rick Wise's trades since 2009 and holding each position for 1 Year would result in 61.38% of your transactions generating a profit, with an average return of 7.6% per rating.

Stock Rating Distribution

513Ratings
84.21% Buy
15.79% Hold
0.00% Sell
Distribution of Rick Wise's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Invuity Inc.
(IVTY)
Rating:Buy
Date:May 04, 2018 - Sep 11, 2018
Return:+162.50%
The most profitable rating made by Rick Wise

Rick Wise's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
~BEAT
BioTelemetry
Dec 16, 2009
Buy
Upgraded
2Ratings
0%
-24.90%
HSP
Hospira Inc
Oct 18, 2011
Hold
Downgraded
2Ratings
100%
+90.30%
Idexx Laboratories
Nov 08, 2012
Hold
Assigned
2Ratings
100%
+5.50%
CFN
Carefusion Corp
Aug 09, 2013
Buy
Reiterated
1Ratings
100%
+14.90%
TRIV
Trivascular Technologies
May 06, 2015
Buy
Reiterated
2Ratings
0%
-31.45%
STJ
St Jude Medical
Oct 22, 2015
Hold
Downgraded
4Ratings
33%
-9.27%
BCR
CR Bard
Jan 27, 2017
Hold
Reiterated
3Ratings
0.00%
SPNC
Spectranetics
Apr 27, 2017
Buy
Reiterated
12Ratings
100%
+54.40%
NVDQ
Novadaq
Jun 20, 2017
Hold
Downgraded
5Ratings
100%
+31.75%
ELGXQ
Endologix
Oct 06, 2017
Hold
Reiterated
10Ratings
14%
-35.03%
List of latest recommendations made by Rick Wise. Click to expand and see Rick Wise's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >